Outcomes from Studies Investigations into this dual therapy have revealed superior weight loss results compared to semaglutide alone, often reaching reductions exceeding 1520% of baseline body weight
Note: Access to full articles may require a subscription or institutional access
BPC-157: Continue 250-500 mcg twice daily Cryotherapy: Once daily post-activity application Introduce progressive loading appropriate to the injury type Monitor for signs of excessive inflammation (increased pain, swelling, heat) Chronic Condition Management Sustained approach for arthritis, chronic tendinopathy, or recurring injuries
When its depleted, everything from immune function to cognitive performance suffers
Use only as directed on the product label
Funding D.A.G is currently supported by grants from the NIH (R01DK094004, R01CA196986, and R01DK116005) and by a Leukemia and Lymphoma Society Career Development Award